New hope for elderly esophageal cancer patients unfit for chemo
NCT ID NCT07205731
First seen Oct 31, 2025 · Last updated May 05, 2026 · Updated 24 times
Summary
This study tests a drug called tislelizumab in people aged 70 and older with advanced esophageal cancer who cannot receive standard chemotherapy. The main goal is to see how many patients are alive after 6 months of treatment. The drug works by helping the immune system fight cancer and is given through an IV. Researchers will also monitor side effects, quality of life, and how long the cancer stays under control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH Béthune et Beuvry
RECRUITINGBeuvry, France
Contact
-
CHRU Brest
RECRUITINGBrest, France
Contact
-
CHRU Lille
RECRUITINGLille, France
Contact
-
CHRU Tours
NOT_YET_RECRUITINGTours, France
Contact
-
CHU Amiens
NOT_YET_RECRUITINGAmiens, France
Contact
-
CHU Besançon
RECRUITINGBesançon, France
Contact
-
CHU Clermont-Ferrand
NOT_YET_RECRUITINGClermont-Ferrand, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU Dijon
NOT_YET_RECRUITINGDijon, France
Contact
-
CHU Limoges
NOT_YET_RECRUITINGLimoges, France
Contact
-
CHU Nancy
RECRUITINGNancy, France
Contact
-
CHU Poitiers
RECRUITINGPoitiers, France
Contact
-
CHU Rennes
RECRUITINGRennes, France
Contact
-
CHU Rouen
RECRUITINGRouen, France
Contact
-
CHU de Reims
NOT_YET_RECRUITINGReims, France
Contact
-
Centre François Baclesse
RECRUITINGCaen, France
Contact
-
Centre Hospitalier Annecy Genevois
NOT_YET_RECRUITINGAnnecy, Epagny Metz-Tessy, 74370, France
Contact
-
Centre Hospitalier de la Côte Basque
NOT_YET_RECRUITINGBayonne, 64100, France
Contact
-
Centre Léon BERARD de Lyon
NOT_YET_RECRUITINGLyon, France
Contact
-
Centre Régional du Lutte Contre Le Cancer - Institut Godinot
NOT_YET_RECRUITINGReims, 51726, France
Contact
-
Centre hospitalier de Perpignan
NOT_YET_RECRUITINGPerpignan, France
Contact
-
Groupe Hospitalier Mutualiste
NOT_YET_RECRUITINGGrenoble, France
Contact
-
Groupe Hospitalier Rance Emeraude
RECRUITINGSt-Malo, France
Contact
-
Hôpital Européen Georges-Pompidou
RECRUITINGParis, France
Contact
-
Hôpital Saint-Louis Lariboisière
RECRUITINGParis, France
Contact
-
ICAN Strasbourg
NOT_YET_RECRUITINGStrasbourg, France
Contact
-
ICHF Centre Pierre Curie
RECRUITINGBeuvry, France
Contact
-
Institut de Cancérologie de l'Ouest
RECRUITINGSaint-Herblain, France
Contact
-
Institut régional du cancer Provence d'Avignon
NOT_YET_RECRUITINGAvignon, France
Contact
-
Le Groupe Hospitalier Diaconesses Croix Saint-Simon de Paris
RECRUITINGParis, France
Contact
-
Médipôle Hôpital Mutualiste
RECRUITINGVilleurbanne, France
Contact
Conditions
Explore the condition pages connected to this study.